The Generics Bulletin Top 50
Who came out on top in a global financial ranking of the most powerful generics and biosimilars companies?
Find out in the 2022 edition of Generics Bulletin’s annual Top 50 ranking of companies in the off-patent sector.
Internal Changes Reflected in Top 10 Shifts
Download your free article pack now to explore this year’s Top 10 rankings – including shake-ups for Sandoz, Sun Pharma, Viatris, and Perrigo.
See who was edged off this elite list and understand how the shift is reshaping the industry landscape, with your free pack.
Download the article packYour trusted source for industry insights
Keep up with the constantly evolving face of the global generics, biosimilars, and value-added medicines industries by arming yourself with vital news, comprehensive data, and penetrating analysis from the worldwide team of experts at Generics Bulletin.
Drive your strategy forward and confidently inform your decision-making with Generics Bulletin’s comprehensive coverage of:
- Regulatory and compliance updates
- Legal and legislative developments
- Competitor activities
- Merger and acquisition news
- New product launches
- Marketing challenges
- Advertising strategies, and more